Therapix Biosciences Ltd Stock TEL AVIV STOCK EXCHANGE
Equities
IL0010951403
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- ILa | - |
|
07-08 | SciSparc Signs Non-Binding Letter of Intent to Spin Off Advanced Clinical Stage Pharmaceutical Portfolio | MT |
06-03 | SciSparc Ltd. Secures Strategic Advantage with Grant of European Patent | CI |
Sales 2022 | 1.35 487.91 1.84 | Sales 2023 | 2.88 1.04K 3.94 | Capitalization | 2.56M 926M 3.5M |
---|---|---|---|---|---|
Net income 2022 | -2M -724M -2.74M | Net income 2023 | -5M -1.81B -6.85M | EV / Sales 2022 | 1,145,812 x |
Net cash position 2022 | 3.55M 1.28B 4.86M | Net cash position 2023 | 5M 1.81B 6.85M | EV / Sales 2023 | -848,893 x |
P/E ratio 2022 |
-1.33
x | P/E ratio 2023 |
-0.34
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.98% |
1st Jan change | Capi. | |
---|---|---|
+25.40% | 45.54B | |
+34.52% | 24.51B | |
+26.09% | 16.48B | |
+21.18% | 14.66B | |
+71.13% | 14.3B | |
-0.05% | 6.79B | |
-11.84% | 6.73B | |
+18.15% | 5.87B | |
-8.87% | 5.73B |